StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
ATHX opened at $0.00 on Wednesday. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99. The firm has a market capitalization of $302,423.10, a price-to-earnings ratio of 0.00 and a beta of -0.90.
About Athersys
Further Reading
- Five stocks we like better than Athersys
- What Are Dividend Contenders? Investing in Dividend Contenders
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
